OBJECTIVES: We investigated possible associations between pain frequency and the 5 most common substance use disorders: alcohol abuse/dependence, cocaine abuse/dependence, methamphetamine abuse/dependence, opioid abuse/dependence, and marijuana abuse/dependence. METHODS: We used data from the Rural Stimulant Study, a longitudinal (7 waves), observational study of at-risk stimulant users (cocaine and methamphetamine) in Arkansas and Kentucky (n=462). In fixed-effects logistic regression models, we regressed our measures of substance use disorders on the number of days with pain in the past 30 days and depression severity. RESULTS: Time periods when individuals had 1 to 15 days [odds ratio (OR)=1.85, P<0.001] or 16+ days (OR=2.18, P<0.001) with pain in the past 30 days were more likely to have a diagnosis of alcohol abuse/dependence, compared with time periods when individuals had no days with pain. Compared with time periods when individuals had no pain days in the past 30 days, time periods when individuals had 16+ pain days were more likely to have a diagnosis of opioid abuse/dependence (OR=3.32, P=0.02). Number of days with pain was not significantly associated with other substance use disorders. DISCUSSION: Pain frequency seems to be associated with an increased risk for alcohol abuse/dependence and opioid abuse/dependence in this population, and the magnitude of the association is medium to large. Further research is needed to investigate this in more representative populations and to determine causal relationships.
OBJECTIVES: We investigated possible associations between pain frequency and the 5 most common substance use disorders: alcohol abuse/dependence, cocaine abuse/dependence, methamphetamine abuse/dependence, opioid abuse/dependence, and marijuana abuse/dependence. METHODS: We used data from the Rural Stimulant Study, a longitudinal (7 waves), observational study of at-risk stimulant users (cocaine and methamphetamine) in Arkansas and Kentucky (n=462). In fixed-effects logistic regression models, we regressed our measures of substance use disorders on the number of days with pain in the past 30 days and depression severity. RESULTS: Time periods when individuals had 1 to 15 days [odds ratio (OR)=1.85, P<0.001] or 16+ days (OR=2.18, P<0.001) with pain in the past 30 days were more likely to have a diagnosis of alcohol abuse/dependence, compared with time periods when individuals had no days with pain. Compared with time periods when individuals had no pain days in the past 30 days, time periods when individuals had 16+ pain days were more likely to have a diagnosis of opioid abuse/dependence (OR=3.32, P=0.02). Number of days with pain was not significantly associated with other substance use disorders. DISCUSSION: Pain frequency seems to be associated with an increased risk for alcohol abuse/dependence and opioid abuse/dependence in this population, and the magnitude of the association is medium to large. Further research is needed to investigate this in more representative populations and to determine causal relationships.
Authors: Jichuan Wang; Robert G Carlson; Russel S Falck; Harvey A Siegal; Ahmmed Rahman; Linna Li Journal: Drug Alcohol Depend Date: 2004-12-22 Impact factor: 4.492
Authors: Michael Von Korff; Paul Crane; Michael Lane; Diana L Miglioretti; Greg Simon; Kathleen Saunders; Paul Stang; Nancy Brandenburg; Ronald Kessler Journal: Pain Date: 2005-02 Impact factor: 6.961
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Y He; M Zhang; E H B Lin; R Bruffaerts; J Posada-Villa; M C Angermeyer; D Levinson; G de Girolamo; H Uda; Z Mneimneh; C Benjet; R de Graaf; K M Scott; O Gureje; S Seedat; J M Haro; E J Bromet; J Alonso; M von Korff; R Kessler Journal: Psychol Med Date: 2008-02-26 Impact factor: 7.723
Authors: Adley Tsang; Michael Von Korff; Sing Lee; Jordi Alonso; Elie Karam; Matthias C Angermeyer; Guilherme Luiz Guimaraes Borges; Evelyn J Bromet; K Demytteneare; Giovanni de Girolamo; Ron de Graaf; Oye Gureje; Jean-Pierre Lepine; Josep Maria Haro; Daphna Levinson; Mark A Oakley Browne; Jose Posada-Villa; Soraya Seedat; Makoto Watanabe Journal: J Pain Date: 2008-07-07 Impact factor: 5.820
Authors: Bradley Neddenriep; Deniz Bagdas; Katherine M Contreras; Joseph W Ditre; Jennifer T Wolstenholme; Michael F Miles; M Imad Damaj Journal: Neuropharmacology Date: 2019-09-25 Impact factor: 5.250
Authors: Teresa J Hudson; Jacob T Painter; Bradley C Martin; Mark A Austen; James S Williams; John C Fortney; Mark D Sullivan; Mark J Edlund Journal: Pain Date: 2017-06 Impact factor: 6.961
Authors: Heather Carney; Ruth Ann Marrie; James M Bolton; Scott B Patten; Lesley A Graff; Charles N Bernstein; Kaarina Kowalec Journal: Inflamm Bowel Dis Date: 2021-01-01 Impact factor: 5.325
Authors: Ryan B Felix; Aniruddha Rao; Mazhar Khalid; Yang Wang; Luana Colloca; Sarah B Murthi; Nicholas A Morris Journal: BMJ Open Date: 2021-11-30 Impact factor: 2.692